Compositions for inhibiting platelet aggregation

Details Compositions for inhibiting platelet aggregation Compositions for inhibiting platelet aggregation

1998-05-15

1999-10-12

Spivack, Phyllis G.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

A61K 31445

Patent

active

059655810

ABSTRACT:
A composition is disclosed comprising about 0.25 mg/ml 2-S-(n-Butylsulfonylamino)-3 -[4-(4-(piperdin-4-yl)butyloxylphenyl]propionic acid, about 8 mg/ml sodium chloride, about 2.7 mg/ml sodium citrate dihydrate, about 0.16 mg/ml citric acid anhydrous, wherein the composition osmolality concentration is between about 250-310 mOsmol/kg and the pH is in the range of between 5.5-6.5.

REFERENCES:
patent: 5733919 (1998-03-01), Gelotte
"Remington's Pharmaceutical Sciences" 16 Edition, Mack Publishing Company, Easton, PA (1980) pp. 1488-1497.
"Handbook of Pharmaceutical Excipients" 2nd Edition, A. Wade and P. Weller, Eds., The Pharmaceutical Press, London (1994) pp. 123-125, 443-444 and 454-458.

Affiliated with

Also associated with

Rating

Compositions for inhibiting platelet aggregation does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compositions for inhibiting platelet aggregation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions for inhibiting platelet aggregation will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-652876